Drug Discovery: market research reports
Drug Discovery market research reports and industry analysis
|
Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... Disorder (ADHD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Attention Deficit Hyperactivity Disorder (ADHD). It includes an overview of the trial numbers and their recruitment status ...
|
read more...
|
$2,500.00
|
|
Cholecystitis Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Cholecystitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...
|
read more...
|
$4,995.00
|
|
PharmaPoint: Multiple Sclerosis - France Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...
|
read more...
|
$4,995.00
|
|
Cryptococcosis Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Cryptococcosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
Thrombophilia Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Thrombophilia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
Hyperphosphatemia Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Hyperphosphatemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
Appendicitis Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Appendicitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... information and data relating to the clinical trials on Leishmaniasis (Kala-Azar). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...
|
read more...
|
$2,500.00
|
|
Nasal Congestion Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... information and data relating to the clinical trials on Nasal Congestion. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...
|
read more...
|
$2,500.00
|
|
Rosacea Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Rosacea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
Pancreatic Fistula Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... information and data relating to the clinical trials on Pancreatic Fistula. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...
|
read more...
|
$2,500.00
|
|
Vitiligo Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Vitiligo. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
Fatigue Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... to the clinical trials on Fatigue. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of ...
|
read more...
|
$2,500.00
|
|
EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022
3/31/2013 | published by: GlobalData
... and Epidermophyton flocossom (Sterry et al., 2006). DO begins as a white/yellow spot under the tip of the nail. As the infection spreads deeper, it causes further discoloration and thickening of the nail, resulting in ...
|
read more...
|
$3,995.00
|
|
Constipation Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Constipation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with ...
|
read more...
|
$4,995.00
|
|
EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022
3/31/2013 | published by: GlobalData
... more than 35,000 cases in the European Union (EU) (Cystic Fibrosis Foundation Patient Registry, 2011; Farrell, 2008). CF causes abnormally thick, sticky mucus to accumulate in the respiratory, digestive, and reproductive systems. It is one ...
|
read more...
|
$3,995.00
|
|
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy ...
|
read more...
|
$4,995.00
|
|
EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022
3/31/2013 | published by: GlobalData
... the health of these tissues and structures, a lack of which causes them to undergo atrophy (Castelo-Branco and Rostro, 2007; Nappi and Kokot-Kierepa, 2012). During the menopause transition and postmenopausal periods, women can experience a ...
|
read more...
|
$3,995.00
|
|
EpiCast Report: Psoriasis - Epidemiology Forecast to 2022
3/31/2013 | published by: GlobalData
... races/ethnicities. The global prevalence of psoriasis varies geographically, with the disease being more prevalent in the colder areas of the north, and less prevalent in the tropics and warmer regions of the world (Weller et ...
|
read more...
|
$3,995.00
|
|
PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...
|
read more...
|
$4,995.00
|
|
Impetigo Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... relating to the clinical trials on Impetigo. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...
|
read more...
|
$2,500.00
|
|
PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022
3/31/2013 | published by: GlobalData
... (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying ...
|
read more...
|
$4,995.00
|
|
Male Hypogonadism Global Clinical Trials Review, H1, 2013
3/31/2013 | published by: GlobalData
... information and data relating to the clinical trials on Male Hypogonadism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook ...
|
read more...
|
$2,500.00
|